首页/数据集/A 2:1 stoichiometric complex of anticancer drug 4'-Epiadriamycin bound to parallel G-quadruplex DNA [d-(TTGGGGT)]4.

A 2:1 stoichiometric complex of anticancer drug 4'-Epiadriamycin bound to parallel G-quadruplex DNA [d-(TTGGGGT)]4.

NIAID Data Ecosystem2026-05-02 收录

G-四链体靶向药物

抗癌药物-DNA复合物结构

数据链接：

https://www.rcsb.org/structure/7CPS 数据链接链接失效反馈

官方服务：

资源简介：

A 2:1 stoichiometric complex of anticancer drug 4'-Epiadriamycin bound to parallel G-quadruplex DNA [d-(TTGGGGT)]4.

应用场景：

创建时间：

2024-05-15

神经退行性疾病治疗

G-四链体靶向药物

The G-quadruplex (G4) forming C9orf72 GGGGCC (G4C2) expanded hexanucleotide repeat (EHR) is the predominant genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Deve

Figshare2022-09-15 更新90

Discovery of a Natural Product-Like c- myc G-Quadruplex DNA Groove-Binder by Molecular Docking

G-四链体靶向药物

分子对接与结构-活性关系

The natural product-like carbamide (1) has been identified as a stabilizer of the c-myc G-quadruplex through high-throughput virtual screening. NMR and molecular modeling experiments revealed a groove

NIAID Data Ecosystem50

Innate immune response to G-quadruplex binders in cancer cells

癌症免疫治疗

G-四链体靶向药物

G-quadruplex (G4) is non-canonical nucleic acid structure involved in a plethora of fundamental biological processes. In past decades, it has been studied as a promising pharmaceutical target for anti

NIAID Data Ecosystem50

Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c‑MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction

G-四链体靶向药物

c-Myc基因调控

c-MYC is one of the important human proto-oncogenes, and transcriptional factor NM23-H2 can activate c-MYC transcription by recognizing the G-quadruplex in the promoter of the gene. Small molecules th

NIAID Data Ecosystem60

Innate immune response to G-quadruplex binders in cancer cells. Innate immune response to G-quadruplex binders in cancer cells

癌症免疫治疗

G-四链体靶向药物

NIAID Data Ecosystem50